Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death

被引：0
|
作者：
Perrine Kafara
Philippe Icard
Marilyne Guillamin
Laurent Schwartz
Hubert Lincet
机构：
[1] INSERM,
[2] U 1199,undefined
[3] Unité BioTICLA,undefined
[4] Normandie Université France,undefined
[5] Centre de Lutte Contre le Cancer François Baclesse,undefined
[6] UMR 7161,undefined
[7] Laboratoire d’Informatique LIX,undefined
[8] Ecole Polytechnique,undefined
[9] UMR INSERM U1052,undefined
[10] CNRS 5286,undefined
[11] Centre de Recherche en Cancérologie de Lyon,undefined
[12] ISPB,undefined
[13] Faculté de Pharmacie de Lyon,undefined
[14] Université de Lyon 1,undefined
来源：
Journal of Ovarian Research | / 8卷
关键词：
Lipoic acid; Mcl-1; Bcl-x; Bim; ovarian cancer; ROS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] GCS-100: A novel therapy for myeloma inhibits Mcl-1, bcl-xL and cell cycle proteins
    Streetly, M. J.
    Su, B.
    Schey, S. A.
    Kazmi, M.
    Cotter, F. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 1 - 2
  • [32] Bak and Bcl-xL Participate in Regulating Sensitivity of Solid Tumor Derived Cell Lines to Mcl-1 Inhibitors
    Senichkin, Viacheslav V.
    Pervushin, Nikolay V.
    Zamaraev, Alexey V.
    Sazonova, Elena V.
    Zuev, Anton P.
    Streletskaia, Alena Y.
    Prikazchikova, Tatiana A.
    Zatsepin, Timofei S.
    Kovaleva, Olga V.
    Tchevkina, Elena M.
    Zhivotovsky, Boris
    Kopeina, Gelina S.
    CANCERS, 2022, 14 (01)
  • [33] Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma
    Gillissen, Bernhard
    Wendt, Jana
    Richter, Antje
    Richter, Anja
    Mueer, Annika
    Overkamp, Tim
    Gebhardt, Nina
    Preissner, Robert
    Belka, Claus
    Doerken, Bernd
    Daniel, Peter T.
    JOURNAL OF CELL BIOLOGY, 2010, 188 (06): : 851 - 862
  • [34] Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies
    Melvold, Katrine
    Giliberto, Mariaserena
    Karlsen, Linda
    Ayuda-Duran, Pilar
    Hanes, Robert
    Holien, Toril
    Enserink, Jorrit
    Brown, Jennifer R.
    Tjonnfjord, Geir E.
    Tasken, Kjetil
    Skanland, Sigrid S.
    MOLECULAR ONCOLOGY, 2022, 16 (05) : 1153 - 1170
  • [35] Endiandric Acid Analogues from Beilschmiedia ferruginea as Dual Inhibitors of Bcl-xL/Bak and Mcl-1/Bid Interactions
    Apel, Cecile
    Geny, Charlotte
    Dumontet, Vincent
    Birlirakis, Nicolas
    Roussi, Fanny
    Van Cuong Pham
    Huong Doan Thi Mai
    Van Hung Nguyen
    Van Minh Chau
    Litaudon, Marc
    JOURNAL OF NATURAL PRODUCTS, 2014, 77 (06): : 1430 - 1437
  • [36] The Interaction Between Cancer-associated Fibroblasts and Cancer Cells Enhances Bcl-xL and Mcl-1 in Colorectal Cancer
    Maeda, Anri
    Takahashi, Hiroki
    Harata, Shinnosuke
    Watanabe, Kaori
    Yanagita, Takeshi
    Suzuki, Takuya
    Ushigome, Hajime
    Nakai, Nozomu
    Maeda, Yuzo
    Hirokawa, Takahisa
    Shiga, Kazuyoshi
    Ogawa, Ryo
    Hara, Masayasu
    Matsuo, Yoichi
    Mitsui, Akira
    Kimura, Masahiro
    Takiguchi, Shuji
    ANTICANCER RESEARCH, 2022, 42 (03) : 1277 - 1288
  • [37] Targeting Bcl-XL enhances arsenic-induced cell death in ovarian cancer cells
    Tekedereli, Ibrahim
    Lopez-Berestein, Gabriel
    Ozpolat, Bulent
    CANCER RESEARCH, 2010, 70
  • [38] First Evidence That Oligopyridines, α-Helix Foldamers, Inhibit Mcl-1 and Sensitize Ovarian Carcinoma Cells to Bcl-xL-Targeting Strategies
    Gloaguen, Celine
    Voisin-Chiret, Anne Sophie
    Santos, Jana Sopkova-de Oliveira
    Fogha, Jade
    Gautier, Fabien
    De Giorgi, Marcella
    Burzicki, Gregory
    Perato, Serge
    Petigny-Lechartier, Cecile
    Simonin-Le Jeune, Karin
    Brotin, Emilie
    Goux, Didier
    N'Diaye, Monique
    Lambert, Bernard
    Louis, Marie-Helene
    Ligat, Laetitia
    Lopez, Frederic
    Juin, Philippe
    Bureau, Ronan
    Rault, Sylvain
    Poulain, Laurent
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (04) : 1644 - 1668
  • [39] The BH3 alpha helical mimic BH3M-6 disrupts Bcl-xL/Bax and Mcl-1/Bax binding and induces apoptosis in human cancer cells in a Bcl-xL, Bcl2 and Mcl-1 dependent manner.
    Kazi, Aslamuzzaman
    Sun, Jiazhi
    Yin, Hang
    Hamilton, Andrew
    Wang, Hong-Gang
    Sebti, Said
    CANCER RESEARCH, 2009, 69
  • [40] BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells
    Perri, Mariarita
    Yap, Jeremy L.
    Yu, Jianshi
    Cione, Erika
    Fletcher, Steven
    Kane, Maureen A.
    EXPERIMENTAL CELL RESEARCH, 2014, 327 (02) : 183 - 191
12345